Cargando…
Recovery of performance and persistent symptoms in athletes after COVID-19
INTRODUCTION: After the acute Sars-CoV-2-infection, some athletes suffer from persistent, performance-impairing symptoms, although the course of the disease is often mild to moderate. The relation between cardiopulmonary performance and persistent symptoms after the acute period is still unclear. In...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728914/ https://www.ncbi.nlm.nih.gov/pubmed/36477204 http://dx.doi.org/10.1371/journal.pone.0277984 |
_version_ | 1784845373208002560 |
---|---|
author | Vollrath, Shirin Bizjak, Daniel Alexander Zorn, Jule Matits, Lynn Jerg, Achim Munk, Moritz Schulz, Sebastian Viktor Waldemar Kirsten, Johannes Schellenberg, Jana Steinacker, Jürgen Michael |
author_facet | Vollrath, Shirin Bizjak, Daniel Alexander Zorn, Jule Matits, Lynn Jerg, Achim Munk, Moritz Schulz, Sebastian Viktor Waldemar Kirsten, Johannes Schellenberg, Jana Steinacker, Jürgen Michael |
author_sort | Vollrath, Shirin |
collection | PubMed |
description | INTRODUCTION: After the acute Sars-CoV-2-infection, some athletes suffer from persistent, performance-impairing symptoms, although the course of the disease is often mild to moderate. The relation between cardiopulmonary performance and persistent symptoms after the acute period is still unclear. In addition, information about the development of this relationship is lacking. OBJECTIVE: To assess the prevalence of persistent symptoms over time and their association with the performance capability of athletes. METHODS: We conducted two cardiopulmonary exercise tests (CPET) in a three months interval with 60 athletes (age: 35.2±12.1 years, 56.7% male) after infection with Sars-CoV-2 (t(0): study inclusion; t(1): three months post t(0)). At each examination, athletes were asked about their persistent symptoms. To evaluate the change of Peak VO(2)/BM (Body Mass) between the time before infection and the first examination, the VO(2)/BM (predVO(2)) before infection was predicted based on anthropometric data and exercise history of the athletes. For data analysis, athletes were grouped according to their symptom status (symptom-free, SF; persistent symptoms, PS) and its progression from the first to the second examination 1) SF-SF, 2) PS-SF and 3) PS-PS. RESULTS: Comparing the SF and PS groups at t(0), significant differences for Max Power/BM, Max Power/lbm (lean body mass), Peak VO(2), Peak VO(2)/BM, Peak VO(2)/lbm, Peak VO(2)/HR, Peak VE, Peak Vt and VE/VCO(2)-Slope were observed. Regarding the progression over three months, an increase in Max Power/BM was shown in SF-SF and PS-SF (tendency). Max Power/lbm increased in SF-SF and PS-PS (tendency). A decrease of VE/VCO(2)-Slope in PS-PS was found. CONCLUSION: COVID-19 led to a decline in performance that was greater in PS than in SF. Additionally, PS had decreased ventilatory parameters compared to SF. Furthermore, an improvement over time was observed in some CPET parameters and a partial recovery was observed judging by the decrease in various symptoms. |
format | Online Article Text |
id | pubmed-9728914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97289142022-12-08 Recovery of performance and persistent symptoms in athletes after COVID-19 Vollrath, Shirin Bizjak, Daniel Alexander Zorn, Jule Matits, Lynn Jerg, Achim Munk, Moritz Schulz, Sebastian Viktor Waldemar Kirsten, Johannes Schellenberg, Jana Steinacker, Jürgen Michael PLoS One Research Article INTRODUCTION: After the acute Sars-CoV-2-infection, some athletes suffer from persistent, performance-impairing symptoms, although the course of the disease is often mild to moderate. The relation between cardiopulmonary performance and persistent symptoms after the acute period is still unclear. In addition, information about the development of this relationship is lacking. OBJECTIVE: To assess the prevalence of persistent symptoms over time and their association with the performance capability of athletes. METHODS: We conducted two cardiopulmonary exercise tests (CPET) in a three months interval with 60 athletes (age: 35.2±12.1 years, 56.7% male) after infection with Sars-CoV-2 (t(0): study inclusion; t(1): three months post t(0)). At each examination, athletes were asked about their persistent symptoms. To evaluate the change of Peak VO(2)/BM (Body Mass) between the time before infection and the first examination, the VO(2)/BM (predVO(2)) before infection was predicted based on anthropometric data and exercise history of the athletes. For data analysis, athletes were grouped according to their symptom status (symptom-free, SF; persistent symptoms, PS) and its progression from the first to the second examination 1) SF-SF, 2) PS-SF and 3) PS-PS. RESULTS: Comparing the SF and PS groups at t(0), significant differences for Max Power/BM, Max Power/lbm (lean body mass), Peak VO(2), Peak VO(2)/BM, Peak VO(2)/lbm, Peak VO(2)/HR, Peak VE, Peak Vt and VE/VCO(2)-Slope were observed. Regarding the progression over three months, an increase in Max Power/BM was shown in SF-SF and PS-SF (tendency). Max Power/lbm increased in SF-SF and PS-PS (tendency). A decrease of VE/VCO(2)-Slope in PS-PS was found. CONCLUSION: COVID-19 led to a decline in performance that was greater in PS than in SF. Additionally, PS had decreased ventilatory parameters compared to SF. Furthermore, an improvement over time was observed in some CPET parameters and a partial recovery was observed judging by the decrease in various symptoms. Public Library of Science 2022-12-07 /pmc/articles/PMC9728914/ /pubmed/36477204 http://dx.doi.org/10.1371/journal.pone.0277984 Text en © 2022 Vollrath et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vollrath, Shirin Bizjak, Daniel Alexander Zorn, Jule Matits, Lynn Jerg, Achim Munk, Moritz Schulz, Sebastian Viktor Waldemar Kirsten, Johannes Schellenberg, Jana Steinacker, Jürgen Michael Recovery of performance and persistent symptoms in athletes after COVID-19 |
title | Recovery of performance and persistent symptoms in athletes after COVID-19 |
title_full | Recovery of performance and persistent symptoms in athletes after COVID-19 |
title_fullStr | Recovery of performance and persistent symptoms in athletes after COVID-19 |
title_full_unstemmed | Recovery of performance and persistent symptoms in athletes after COVID-19 |
title_short | Recovery of performance and persistent symptoms in athletes after COVID-19 |
title_sort | recovery of performance and persistent symptoms in athletes after covid-19 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728914/ https://www.ncbi.nlm.nih.gov/pubmed/36477204 http://dx.doi.org/10.1371/journal.pone.0277984 |
work_keys_str_mv | AT vollrathshirin recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT bizjakdanielalexander recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT zornjule recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT matitslynn recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT jergachim recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT munkmoritz recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT schulzsebastianviktorwaldemar recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT kirstenjohannes recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT schellenbergjana recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 AT steinackerjurgenmichael recoveryofperformanceandpersistentsymptomsinathletesaftercovid19 |